Access the full text.
Sign up today, get DeepDyve free for 14 days.
Eric Thervet, D. Anglicheau, Nathalie Toledano, Anne-Marie Houllier, Laure-Hélène Noël, H. Kreis, Philippe Beaune, C. Legendre (2001)
Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.Journal of the American Society of Nephrology : JASN, 12 1
M. Ameyaw, M. Ameyaw, E. Collie-Duguid, R. Powrie, David Ofori-Adjei, Howard McLeod (1999)
Thiopurine methyltransferase alleles in British and Ghanaian populations.Human molecular genetics, 8 2
W. Evans (2004)
Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine TherapyTherapeutic Drug Monitoring, 26
C. Moureyre, H. Debuysère, N. Sabbagh, D. Marez, E. Vinner, Emmanuel Chevalier, J. Guidice, F. Broly (1998)
Detection of known and new mutations in the thiopurine S‐methyltransferase gene by single‐strand conformation polymorphism analysisHuman Mutation, 12
Yuen Hon, M. Fessing, C. Pui, C. Pui, M. Relling, M. Relling, E. Krynetski, E. Krynetski, William Evans, William Evans (1999)
Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.Human molecular genetics, 8 2
R. Weinshilboum, S. Sladek (1980)
Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.American journal of human genetics, 32 5
T. Loennechen, E. Utsi, I. Hartz, R. Lysaa, H. Kildalsen, J. Aarbakke (2001)
Detection of one single mutation predicts thiopurine S‐methyltransferase activity in a population of Saami in northern NorwayClinical Pharmacology & Therapeutics, 70
E. Krynetski, W. Evans (2003)
Drug methylation in cancer therapy: lessons from the TPMT polymorphismOncogene, 22
C. Szumlanski, D. Otterness, C. Her, Daniel Lee, B. Brandriff, D. Kelsell, N. Spurr, L. Lennard, E. Wieben, R. Weinshilboum (1996)
Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism.DNA and cell biology, 15 1
E. Krynetski, Hung-Liang Tai, Charles Yates, M. Fessing, T. Loennechen, John Schuetz, M. Relling, William Evans (1996)
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.Pharmacogenetics, 6 4
E. Krynetski, J. Schuetz, A. Galpin, C. Pui, M. Relling, W. Evans (1995)
A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.Proceedings of the National Academy of Sciences of the United States of America, 92 4
Y. Okada, Katsunori Nakamura, M. Wada, Tetsuya Nakamura, N. Tsukamoto, Y. Nojima, R. Horiuchi, Koujirou Yamamoto (2005)
Genotyping of thiopurine methyltransferase using pyrosequencing.Biological & pharmaceutical bulletin, 28 4
S. Cheung, R. Allan (2003)
Mistaken identity: misclassification of TPMT phenotype following blood transfusion.European journal of gastroenterology & hepatology, 15 11
C. Remy (1963)
Metabolism of thiopyrimidines and thiopurines. S-Methylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissues.The Journal of biological chemistry, 238
Jan-Gowth Chang, Long-Shyong Lee, Chih-Mei Chen, M. Shih, Mei‐Chen Wu, F. Tsai, Der-Cheng Liang (2002)
Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations.Pharmacogenetics, 12 3
M. Kurzawski, B. Gawrońska-Szklarz, M. Droździk (2004)
Frequency Distribution of Thiopurine S-Methyltransferase Alleles in a Polish PopulationTherapeutic Drug Monitoring, 26
E. Schütz, N. Ahsen, M. Oellerich (2000)
Genotyping of eight thiopurine methyltransferase mutations: three-color multiplexing, "two-color/shared" anchor, and fluorescence-quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design.Clinical chemistry, 46 11
G. Elion (1989)
The purine path to chemotherapyIn Vitro Cellular & Developmental Biology, 25
H. McLeod, Jin‐sying Lin, Edward Scott, C. Pui, W. Evans (1994)
Thiopurine methyltransferase activity in American white subjects and black subjectsClinical Pharmacology & Therapeutics, 55
N. Sorokin, V. Chechetkin, M. Livshits, S. Pan'kov, M. Donnikov, D. Gryadunov, S. Lapa, A. Zasedatelev (2005)
Discrimination Between Perfect and Mismatched Duplexes with Oligonucleotide Gel Microchips: Role of Thermodynamic and Kinetic Effects During HybridizationJournal of Biomolecular Structure and Dynamics, 22
E. Schaeffeler, C. Fischer, D. Brockmeier, D. Wernet, K. Moerike, M. Eichelbaum, U. Zanger, M. Schwab (2004)
Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.Pharmacogenetics, 14 7
L. Lennard, T. Chew, J. Lilleyman (2001)
Human thiopurine methyltransferase activity varies with red blood cell age.British journal of clinical pharmacology, 52 5
Charles Yates, E. Krynetski, T. Loennechen, M. Fessing, H. Tai, C. Pui, M. Relling, William Evans (1997)
Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine IntoleranceAnnals of Internal Medicine, 126
S. Bavykin, J. Akowski, V. Zakhariev, Viktor Barsky, A. Perov, A. Mirzabekov (2001)
Portable System for Microbial Sample Preparation and Oligonucleotide Microarray AnalysisApplied and Environmental Microbiology, 67
D. Otterness, C. Szumlanski, L. Lennard, B. Klemetsdal, J. Aarbakke, J. Park-Hah, H. Iven, K. Schmiegelow, E. Branum, J. O’Brien, R. Weinshilboum (1997)
Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphismsClinical Pharmacology & Therapeutics, 62
A. Kolchinskiĭ, D. Griadunov, Iu Lysov, V. Mikhailovich, T. Nasedkina, A. Turygin, A. Rubina, V. Barskiĭ, A. Zasedatelev (2004)
[Microchips based on three dimensional gel cells: history and perspective].Molekuliarnaia biologiia, 38 1
D. Otterness, C. Szumlanski, T. Wood, R. Weinshilboum (1998)
Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.The Journal of clinical investigation, 101 5
H. McLeod, S. Pritchard, Jessie Githang, A. Indalo, M. Ameyaw, R. Powrie, L. Booth, E. Collie-Duguid (1999)
Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.Pharmacogenetics, 9 6
A. Rubina, S. Pan'kov, E. Dementieva, D.N Pen’kov, A. Butygin, V. Vasiliskov, A. Chudinov, A. Mikheikin, V. Mikhailovich, A. Mirzabekov (2004)
Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production.Analytical biochemistry, 325 1
E. Collie-Duguid, S. Pritchard, R. Powrie, J. Sludden, D. Collier, Tao Li, Howard McLeod (1999)
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.Pharmacogenetics, 9 1
Thiopurine drugs are metabolized, in part, by S-methylation catalyzed by thiopurine S-methyltransferase (TPMT). Patients with very low or undetectable TPMT activity are at high risk of severe, potentially fatal hematopoietic toxicity when they are treated with standard doses of thiopurines. As human TPMT activity is controlled by a common genetic polymorphism, it is an excellent candidate for the clinical application of pharmacogenetics. Here, we report a new molecular approach developed to detect point mutations in the TPMT gene that cause the loss of TPMT activity. A fluorescently labeled amplified DNA is hybridized with oligonucleotide DNA probes immobilized in gel pads on a biochip. The specially designed TPMT biochip can recognize six point mutations in the TPMT gene and seven corresponding alleles associated with TPMT deficiency: TPMT * 2; TPMT * 3A, TPMT * 3B, TPMT * 3C, TPMT * 3D, TPMT * 7, and TPMT * 8. The effectiveness of the protocol was tested by genotyping 58 samples of known genotype. The results showed 100% concordance between the biochip-based approach and the established PCR protocol. The genotyping procedure is fast, reliable and can be used for rapid screening of inactivating mutations in the TPMT gene. The study also provides the first data on the frequency of common TPMT variant alleles in the Russian population, based on a biochip analysis of 700 samples. TPMT gene mutations were identified in 44 subjects; genotype *1/*3A was most frequent.
European Journal of Human Genetics – Springer Journals
Published: May 17, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.